GGenetics Read More Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal21 May 2025 Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction for…
GGenetics Read More 23andMe will have court-appointed overseer for genetic data in bankruptcy29 April 2025 By Dietrich Knauth NEW YORK (Reuters) -Genetic testing company 23andMe agreed on Tuesday to allow a court-appointed overseer…
GGenetics Read More WHAT THE TECH? How the sale of genetics testing company could impact you | Local News26 April 2025 Millions of Americans have embraced at-home DNA kits, hoping to unlock the secrets of their family trees and…
GGenetics Read More Here’s What Potential 23andMe Buyers Could Do With Your Genetic Data21 April 2025 Late last month, genetic testing giant 23andMe filed for bankruptcy. The San Francisco-based company — cofounded in 2006…